MWA
ABBV icon

Moser Wealth Advisors’s AbbVie ABBV Stock Holding History

Moser Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.53M Buy
13,619
+279
+2% +$51.9K 1.21% 21
2025
Q1 		$2.79M Sell
13,340
-268
-2% -$52.1K 1.46% 20
2024
Q4 		$2.42M Sell
13,608
-135
-1% -$24.8K 1.26% 20
2024
Q3 		$2.71M Hold
13,743
– – 1.41% 18
2024
Q2 		$2.36M Buy
13,743
+325
+2% +$53.8K 1.28% 21
2024
Q1 		$2.44M Buy
13,418
+40
+0.3% +$6.89K 1.36% 20
2023
Q4 		$2.07M Sell
13,378
-95
-0.7% -$13.8K 1.32% 21
2023
Q3 		$2.01M Hold
13,473
– – 1.41% 19
2023
Q2 		$1.82M Buy
+13,473
New +$1.98M 1.22% 22
2022
Q4 		$2.24M Sell
13,848
-65
-0.5% -$9.97K 1.69% 16
2022
Q3 		$1.87M Hold
13,913
– – 1.46% 19
2022
Q2 		$2.13M Buy
13,913
+2
+0% +$306 1.58% 15
2022
Q1 		$2.25M Hold
13,911
– – 1.41% 19
2021
Q4 		$1.88M Buy
13,911
+125
+0.9% +$14.8K 1.14% 24
2021
Q3 		$1.49M Buy
13,786
+200
+1% +$22.9K 0.95% 26
2021
Q2 		$1.53M Buy
13,586
+150
+1% +$16.9K 0.99% 25
2021
Q1 		$1.45M Sell
13,436
-550
-4% -$58.8K 1.02% 23
2020
Q4 		$1.5M Hold
13,986
– – 1.11% 22
2020
Q3 		$1.23M Sell
13,986
-120
-0.9% -$11.3K 0.97% 26
2020
Q2 		$1.39M Sell
14,106
-150
-1% -$13.2K 1.32% 21
2020
Q1 		$1.09M Buy
14,256
+5,025
+54% +$428K 1.26% 19
2019
Q4 		$817K Buy
+9,231
New +$766K 0.78% 30

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Moser Wealth Advisors's ABBV Position: Q2 2025 in Review

Moser Wealth Advisors increased its AbbVie (ABBV) stake by 2.1% in Q2 2025, buying an estimated $51.9K and bringing the position to 13,619 shares worth $2.53M. The position accounts for 1.21% of the portfolio, ranked #21.

Moser Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 22 quarters since. The position peaked at $2.79M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Moser Wealth Advisors held 13,619 shares of AbbVie worth $2.53M as of Q2 2025.
  • Moser Wealth Advisors bought 279 AbbVie shares in Q2 2025, an estimated $51.9K.
  • AbbVie made up 1.21% of Moser Wealth Advisors's portfolio in Q2 2025, its #21 holding.
  • Moser Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 22 quarters since.
  • Moser Wealth Advisors's AbbVie position peaked at $2.79M in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Moser Wealth Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.